Skip to main content
. 2020 Apr 24;52(1):155–162. doi: 10.1007/s42770-020-00280-7

Table 1.

Description of the itraconazole formulations acquired as oral capsules according to the manufacturers

IDa Origin Use Concentrationc Origin of the pharmaceutical company
H-INDb Brand name Human 10 mg/mL Beerse, Belgium
V-IND Brand name Veterinary 2.5 mg/mL São Paulo, SP, Brazil
H-COMP1 Compounded Human 6.4 mg/mL Pelotas, RS, Brazil
H-COMP2 Compounded Human 6.5 mg/mL Pelotas, RS, Brazil
V-COMP Compounded Veterinary 6.4 mg/mL Pelotas, RS, Brazil

aID identification

bReference drug

cConcentration after dissolution, according to the M38-A2 guidelines [12]